Divi's Labs, Laurus Labs, Gland Pharma See Weak U.S. Exports In April

Divi's Laboratories Ltd., Laurus Labs Ltd. and Gland Pharma Ltd. reported low U.S. exports figures during April, according to data obtained by IIFL Securities Ltd.

For formulation companies, Jeewani said that the export data is not as reliable as for others. However, among these formulation drugmakers:

• Dr Reddy’s Laboratories Ltd. and Zydus Lifesciences Ltd. seem to have benefited from higher gRevlimid (lenalidomide—blood cancer treatment drug) shipments in April.

• Sun Pharmaceutical Industries Ltd.'s export numbers for April were muted, partly driven by the decline in gRevlimid shipments.

• Aurobindo Pharma Ltd., Cipla Ltd., Lupin Ltd. and Torrent Pharmaceuticals Ltd, also exhibited largely muted trends in April.